Mathur Ashwini, Sankar Vivek
Novartis Healthcare Private Limited, Hyderabad, India.
J Ayurveda Integr Med. 2010 Jan;1(1):52-5. doi: 10.4103/0975-9476.59828.
Reported lack of efficacy of Ayurvedic treatments in clinical trials is often not due to inefficacy of the treatment itself, but arises from inadequacies of trial design. This paper argues that trials of Ayurvedic interventions should exclusively use its multi-component, individualized and inherently holistic approach, and that general guidelines for rigorously reporting such clinical trials should be developed. Holistic Ayurvedic clinical trials, rigorously conducted and with high standards of reporting should translate into good clinical science, and may be expected to generate higher credibility for clinical studies of the Ayurvedic knowledge system.
在临床试验中报告的阿育吠陀疗法缺乏疗效，往往并非该疗法本身无效，而是源于试验设计的不足。本文认为，阿育吠陀干预措施的试验应专门采用其多成分、个体化且本质上整体的方法，并且应制定严格报告此类临床试验的通用指南。严格开展并高标准报告的整体阿育吠陀临床试验应能转化为良好的临床科学，并有望为阿育吠陀知识体系的临床研究带来更高的可信度。
